Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Sprache: | English |
Veröffentlicht: |
BMJ Publishing Group
2021
|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Sprache: | English |
Veröffentlicht: |
BMJ Publishing Group
2021
|